A detailed history of Sg Americas Securities, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 1,941 shares of REGN stock, worth $1.34 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,941
Previous 23,355 91.69%
Holding current value
$1.34 Million
Previous $24.6 Million 94.37%
% of portfolio
0.01%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

SELL
$701.85 - $1046.91 $15 Million - $22.4 Million
-21,414 Reduced 91.69%
1,941 $1.38 Million
Q3 2024

Oct 03, 2024

SELL
$1024.09 - $1201.76 $17.5 Million - $20.5 Million
-17,056 Reduced 42.21%
23,355 $24.6 Million
Q2 2024

Jul 12, 2024

BUY
$883.2 - $1071.19 $26.4 Million - $32 Million
29,901 Added 284.5%
40,411 $42.5 Million
Q1 2024

May 06, 2024

BUY
$902.69 - $993.35 $2.92 Million - $3.21 Million
3,235 Added 44.47%
10,510 $10.1 Million
Q4 2023

Jan 12, 2024

SELL
$775.18 - $881.7 $13.1 Million - $14.9 Million
-16,866 Reduced 69.86%
7,275 $6.39 Million
Q3 2023

Oct 13, 2023

SELL
$692.45 - $844.37 $13.9 Million - $16.9 Million
-20,021 Reduced 45.34%
24,141 $19.9 Million
Q2 2023

Jul 10, 2023

BUY
$700.03 - $830.35 $11.9 Million - $14.1 Million
17,037 Added 62.81%
44,162 $31.7 Million
Q1 2023

Apr 28, 2023

BUY
$680.49 - $826.97 $2.98 Million - $3.63 Million
4,384 Added 19.28%
27,125 $22.3 Million
Q4 2022

Feb 02, 2023

BUY
$705.89 - $766.39 $7.38 Million - $8.01 Million
10,452 Added 85.05%
22,741 $16.4 Million
Q3 2022

Oct 31, 2022

BUY
$573.97 - $724.32 $2.96 Million - $3.73 Million
5,154 Added 72.24%
12,289 $8.47 Million
Q2 2022

Jul 29, 2022

SELL
$548.35 - $738.84 $639,924 - $862,226
-1,167 Reduced 14.06%
7,135 $4.22 Million
Q1 2022

Apr 29, 2022

SELL
$595.12 - $698.43 $951,001 - $1.12 Million
-1,598 Reduced 16.14%
8,302 $5.8 Million
Q4 2021

Feb 07, 2022

BUY
$543.48 - $670.97 $3.77 Million - $4.66 Million
6,942 Added 234.69%
9,900 $6.25 Million
Q3 2021

Nov 01, 2021

SELL
$574.03 - $680.96 $9.97 Million - $11.8 Million
-17,368 Reduced 85.45%
2,958 $1.79 Million
Q2 2021

Aug 12, 2021

BUY
$472.8 - $558.54 $3.38 Million - $3.99 Million
7,151 Added 54.28%
20,326 $11.4 Million
Q1 2021

May 13, 2021

SELL
$446.73 - $548.2 $2.2 Million - $2.69 Million
-4,915 Reduced 27.17%
13,175 $6.23 Million
Q4 2020

Feb 04, 2021

SELL
$478.3 - $607.98 $3.29 Million - $4.18 Million
-6,880 Reduced 27.55%
18,090 $8.74 Million
Q3 2020

Nov 09, 2020

BUY
$544.75 - $658.21 $4.34 Million - $5.25 Million
7,974 Added 46.92%
24,970 $14 Million
Q2 2020

Jul 20, 2020

BUY
$493.32 - $643.92 $1.73 Million - $2.25 Million
3,500 Added 25.93%
16,996 $10.6 Million
Q1 2020

Apr 30, 2020

BUY
$336.18 - $494.43 $817,925 - $1.2 Million
2,433 Added 21.99%
13,496 $6.59 Million
Q4 2019

Jan 28, 2020

SELL
$274.13 - $376.51 $9.39 Million - $12.9 Million
-34,248 Reduced 75.58%
11,063 $4.15 Million
Q3 2019

Nov 04, 2019

SELL
$273.46 - $318.39 $12.6 Million - $14.6 Million
-46,010 Reduced 50.38%
45,311 $12.6 Million
Q2 2019

Jul 29, 2019

BUY
$299.6 - $414.82 $19.3 Million - $26.7 Million
64,442 Added 239.75%
91,321 $28.6 Million
Q1 2019

Apr 29, 2019

BUY
$372.08 - $439.57 $4.52 Million - $5.34 Million
12,141 Added 82.38%
26,879 $11 Million
Q4 2018

Feb 01, 2019

SELL
$335.82 - $403.04 $4.89 Million - $5.87 Million
-14,557 Reduced 49.69%
14,738 $5.51 Million
Q3 2018

Nov 06, 2018

BUY
$351.14 - $408.51 $8.67 Million - $10.1 Million
24,705 Added 538.24%
29,295 $11.8 Million
Q2 2018

Aug 07, 2018

SELL
$284.6 - $344.99 $3.94 Million - $4.77 Million
-13,830 Reduced 75.08%
4,590 $1.58 Million
Q1 2018

May 03, 2018

BUY
$315.82 - $393.78 $2.65 Million - $3.3 Million
8,378 Added 83.43%
18,420 $6.34 Million
Q4 2017

Jan 24, 2018

SELL
$358.63 - $469.95 $38,014 - $49,814
-106 Reduced 1.04%
10,042 $3.78 Million
Q3 2017

Nov 07, 2017

BUY
$431.38 - $504.0 $4.38 Million - $5.11 Million
10,148
10,148 $4.54 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $73.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.